Presenter: Carmelo Scarpignato, MD, DSc, PharmD, MPH

Original Date: June 4, 2016

SIBO is a challenging clinical condition. Its etiology is usually complex and multifactorial and the syndrome is often misdiagnosed and generally under-diagnosed. Clinical symptoms may be subtle and non-specific, which makes diagnosis difficult without objective testing. The availability of poorly absorbed antimicrobials (i.e. rifaximin) has been an advance in treatment, which needs to be refined to identify the best dose and duration to maximize eradication and prevent recurrence. The global management of patients with SIBO will be, however, multifactorial (including nutritional support and dealing with the underlying abnormalities) and long-term care.

1.0 Pharmacology CEUs approved by OBNM